Biochemical and Biophysical Research Communications
Cancer epigenetics: Now harvesting fruit and seeding for common diseases
References (16)
- et al.
Somatic alterations and dysregulation of epigenetic modifiers in cancers
Biochem. Biophys. Res. Commun.
(2014) - et al.
The role of mutation of metabolism-related genes in genomic hypermethylation
Biochem. Biophys. Res. Commun.
(2014) - et al.
Epigenetic regulation leading to induced pluripotency drives cancer development in vivo
Biochem. Biophys. Res. Commun.
(2014) - et al.
Compendium of aberrant DNA methylation and histone modifications in cancer
Biochem. Biophys. Res. Commun.
(2014) - et al.
Biological significance of the CpG island methylator phenotype
Biochem. Biophys. Res. Commun.
(2014) - et al.
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer
Biochem. Biophys. Res. Commun.
(2014) - et al.
Development and classes of epigenetic drugs for cancer
Biochem. Biophys. Res. Commun.
(2014) - et al.
Epigenetic epidemiology of cancer
Biochem. Biophys. Res. Commun.
(2014)
Cited by (9)
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
2021, Advanced Drug Delivery ReviewsCitation Excerpt :This mechanism enables temporal and spatial control of gene activity during the formation of complex organisms. However, anomalous changes in epigenetic processes can be contributed to the malignant transformation of normal cells. [62–64] Recent advances in the study of cancer epigenetics have indicated that epigenetic-related gene might be promising target for anti-tumor therapy.
Wolf–Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation
2017, Neoplasia (United States)Citation Excerpt :It is not surprising that mutations in epigenetic factors lead to tumorigenesis, because epigenetic mechanisms had long been recognized as fundamental driving force during genesis and progression of cancer cells. Accumulating evidences showed that the malignant transformation of normal cells requires an extensive epigenomic reconfiguration [34–36]. Being one of the major epigenetic mechanisms, histone modifications were often found dysregulated in cancer cells, which led to uncontrolled gene expression and cell proliferation.
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates
2016, Bioorganic and Medicinal Chemistry LettersDesign, Synthesis, and Cytotoxic Evaluation of Novel Lupane Triterpenoid Derived Hydroxamates
2020, Natural Product CommunicationsPHLPP2 is a novel biomarker and epigenetic target for the treatment of Vitamin C in pancreatic cancer
2020, International Journal of Oncology